Bekes Megyei Pandy Kalman Korhaz
About Bekes Megyei Pandy Kalman Korhaz
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Shire
10
Hoffmann-La Roche
8
Janssen Research & Development, LLC
8
Amgen
7
Celgene
7
Pfizer
5
Eli Lilly and Company
4
Sunovion
4
H. Lundbeck A/S
3
Takeda
3
AVEO Pharmaceuticals, Inc.
2
Clinical Trials at Bekes Megyei Pandy Kalman Korhaz
During the past decade, Bekes Megyei Pandy Kalman Korhaz conducted 69 clinical trials. In the 10-year time frame, 69 clinical trials started and 47 clinical trials were completed, i.e. on
average, 68.1% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 27 clinical trials were completed. i.e. 168.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
BBR 2778 for Relapsed, Aggressive Non-Hodgkin's Lymphoma (NHL)
2004-07-01
2010-07-01
Completed
140
Study of COLAL-PRED® in the Treatment of Moderate Acute Ulcerative Colitis
2006-03-01
2008-04-01
Completed
796
Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain
2007-08-01
2008-03-01
Completed
148
A Study of Oseltamivir (Tamiflu) for Treatment of Influenza in Immunocompromised Participants.
2008-02-04
2017-05-02
Completed
228
Adjunctive Zonisamide in Primary Generalised Tonic Clonic Seizures
2008-08-01
2009-01-09
Terminated
21
Efficacy and Safety of Adjunctive Zonisamide in Myoclonic Seizures Associated With Idiopathic Generalised Epilepsy
2008-06-01
Terminated
10
Randomized, Double-blind Safety and Efficacy Study of Lisdexamfetamine Dimesylate (LDX) in Children and Adolescents Aged 6-17
2008-11-17
2011-03-16
Completed
336
Double-blind, Placebo-controlled, Randomised Withdrawal, Extension, Safety and Efficacy Study of LDX in Children and Adolescents Aged 6-17
2009-01-27
2011-10-26
Completed
276
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Bekes Megyei Pandy Kalman Korhaz" #1 sponsor was "Shire" with 10 trials, followed by "Hoffmann-La Roche" with 8 trials
sponsored, "Janssen Research & Development, LLC" with 8 trials sponsored, "Amgen" with 7 trials sponsored and "Celgene"
with 7 trials sponsored. Other sponsors include 63 different institutions and
companies that sponsored additional 53 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Bekes Megyei Pandy Kalman Korhaz"
#1 collaborator was "Daiichi Sankyo Co., Ltd." with 2 trials as a collaborator, "APCER Life Sciences" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator, "AstraZeneca" with 1 trials as a collaborator and "BioInvent International AB" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were
collaborators in the rest 26 trials.
Clinical Trials Conditions at Bekes Megyei Pandy Kalman Korhaz
According to Clinical.Site data, the most researched conditions in "Bekes Megyei Pandy Kalman Korhaz" are
"Ulcerative Colitis" (14 trials), "Crohn's Disease" (9 trials), "Crohn Disease" (8 trials), "Systemic Lupus Erythematosus" (5 trials) and "Arthritis, Psoriatic" (4 trials). Many other conditions were trialed in "Bekes Megyei Pandy Kalman Korhaz" in a lesser frequency.
Clinical Trials Intervention Types at Bekes Megyei Pandy Kalman Korhaz
Most popular intervention types in "Bekes Megyei Pandy Kalman Korhaz" are "Drug" (101 trials), "Other" (13 trials), "Biological" (6 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (50 trials), "Etrolizumab" (4 trials), "Guselkumab" (4 trials), "Ontamalimab" (4 trials) and "Ozanimod" (3 trials). Other intervention names were less common.
Clinical Trials Genders at Bekes Megyei Pandy Kalman Korhaz
The vast majority of trials in "Bekes Megyei Pandy Kalman Korhaz" are
104 trials for "All" genders and 4 trials for "Male" genders.
Clinical Trials Status at Bekes Megyei Pandy Kalman Korhaz
Currently, there are NaN active trials in "Bekes Megyei Pandy Kalman Korhaz".
undefined are not yet recruiting,
17 are recruiting,
16 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 53 completed trials in Bekes Megyei Pandy Kalman Korhaz,
undefined suspended trials,
and 19 terminated clinical trials to date.
Out of the total trials that were conducted in Bekes Megyei Pandy Kalman Korhaz, 1 "Phase 1"
clinical trials were conducted, 27 "Phase 2" clinical
trials and 77 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 5 trials, and there were
also 1 trials that are defined as “Not Applicable".
Departments of Bekes Megyei Pandy Kalman Korhaz
Bekes Megyei Pandy Kalman Korhaz has several departments that took part in Clinical trials: "Békés Megyei Pándy Kálmán Kórház; Onkologiai tanszek" - 7 trials, "Bekes Megyei Kosponti Korhaz, Dr. Rethy Pal Tagkorhaz, IV. Belgyogyaszat - 2. Gasztroenterologia" - 6 trials
Departments List